Benzinga Rankings give you vital metrics on any stock – anytime.
Explore PharmaCyte Biotech stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PMCB.
You can purchase shares of PharmaCyte Biotech (NASDAQ:PMCB) through any online brokerage.
Other companies in PharmaCyte Biotech’s space includes: Tharimmune (NASDAQ:THAR), Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX), Intensity Therapeutics (NASDAQ:INTS) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
There is no analysis for PharmaCyte Biotech to provide a consensus price target.
The stock price for PharmaCyte Biotech (NASDAQ: PMCB) is $1.05 last updated June 26, 2025 at 4:07 PM EDT.
There are no upcoming dividends for PharmaCyte Biotech.
PharmaCyte Biotech’s Q1 earnings are confirmed for Tuesday, September 16, 2025.
There is no upcoming split for PharmaCyte Biotech.
PharmaCyte Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.